Calcium-sensing receptor promotes calcium oxalate crystal adhesion and renal injury in Wistar rats by promoting ROS production and subsequent regulation of PS ectropion, OPN, KIM-1, and ERK expression

References

• Thongboonkerd V. Proteomics of crystal–cell interactions: a model for kidney stone research. Cells. 2019;8(9):1076.
   Web of Science ®Google Scholar
• Yu L, Gan X, Liu X, et al. Calcium oxalate crystals induces tight junction disruption in distal renal tubular epithelial cells by activating ROS/Akt/p38 MAPK signaling pathway. Ren Fail. 2017;39(1):440–451.
   PubMed Web of Science ®Google Scholar
• Convento MB, Pessoa EA, Cruz E, et al. Calcium oxalate crystals and oxalate induce an epithelial-to-mesenchymal transition in the proximal tubular epithelial cells: contribution to oxalate kidney injury. Sci Rep. 2017;7:45740.
   PubMedGoogle Scholar
• Zhu W, Zhao Z, Chou FJ, et al. The protective roles of estrogen receptor β in renal calcium oxalate crystal formation via reducing the liver oxalate biosynthesis and renal oxidative stress-mediated cell injury. Oxid Med Cell Longev. 2019;2019:5305014.
   PubMed Web of Science ®Google Scholar
• Li X, Ma J, Shi W, et al. Calcium oxalate induces renal injury through calcium-sensing receptor. Oxid Med Cell Longev. 2016;2016:5203801.
   PubMed Web of Science ®Google Scholar
• Hannan FM, Kallay E, Chang W, et al. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol. 2018;15(1):33–51.
   PubMed Web of Science ®Google Scholar
• Riccardi D, Valenti G. Localization and function of the renal calcium-sensing receptor. Nat Rev Nephrol. 2016;12(7):414–425.
   PubMed Web of Science ®Google Scholar
• Gerbino A, Colella M. The different facets of extracellular calcium sensors: old and new concepts in calcium-sensing receptor signalling and pharmacology. Int J Mol Sci. 2018;19(4):999.
   Web of Science ®Google Scholar
• Vezzoli G, Terranegra A, Soldati L. Calcium-sensing receptor gene polymorphisms in patients with calcium nephrolithiasis. Curr Opin Nephrol Hypertens. 2012;21(4):355–361.
   PubMed Web of Science ®Google Scholar
• Guha M, Bankura B, Ghosh S, et al. Polymorphisms in CaSR and CLDN14 genes associated with increased risk of kidney stone disease in patients from the Eastern Part of India. PLoS One. 2015;10(6):e0130790.
   PubMed Web of Science ®Google Scholar
• Dimke H, Desai P, Borovac J, et al. Activation of the Ca(2+)-sensing receptor increases renal claudin-14 expression and urinary Ca(2+) excretion. Am J Physiol Renal Physiol. 2013;304(6):F761–F769.
   PubMed Web of Science ®Google Scholar
• de Water R, Boeve ER, van Miert PP, et al. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. Scanning Microsc. 1996;10(2):591–601, discussion 601–603.
   PubMedGoogle Scholar
• Abhishek A, Benita S, Kumari M, et al. Molecular analysis of oxalate-induced endoplasmic reticulum stress mediated apoptosis in the pathogenesis of kidney stone disease. J Physiol Biochem. 2017;73(4):561–573.
   PubMed Web of Science ®Google Scholar
• Boonla C, Wunsuwan R, Tungsanga K, et al. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007;35(4):185–191.
   PubMedGoogle Scholar
• Poljsak B, Suput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev. 2013;2013:956792.
   PubMed Web of Science ®Google Scholar
• Zuo J, Khan A, Glenton PA, et al. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-l-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant. 2011;26(6):1785–1796.
   PubMed Web of Science ®Google Scholar
• Schroit AJ, Zwaal RF. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta. 1991;1071(3):313–329.
   PubMedGoogle Scholar
• Yu SL, Gan XG, Huang JM, et al. Oxalate impairs aminophospholipid translocase activity in renal epithelial cells via oxidative stress: implications for calcium oxalate urolithiasis. J Urol. 2011;186(3):1114–1120.
   PubMed Web of Science ®Google Scholar
• McCubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006;8(9–10):1775–1789.
   PubMed Web of Science ®Google Scholar
• Luo Z, Luo W, Li S, et al. Reactive oxygen species mediated placental oxidative stress, mitochondrial content, and cell cycle progression through mitogen-activated protein kinases in intrauterine growth restricted pigs. Reprod Biol. 2018;18(4):422–431.
   PubMed Web of Science ®Google Scholar
• Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene. 2007;26(22):3203–3213.
   PubMed Web of Science ®Google Scholar
• Qi H, Cao Y, Huang W, et al. Crucial role of calcium-sensing receptor activation in cardiac injury of diabetic rats. PLoS One. 2013;8(5):e65147.
   PubMed Web of Science ®Google Scholar
• Ranieri M. Renal Ca(2+) and water handling in response to calcium sensing receptor signaling: physiopathological aspects and role of CaSR-regulated microRNAs. Int J Mol Sci. 2019;20(21):5341.
   Web of Science ®Google Scholar
• Riccardi D, Park J, Lee WS, et al. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A. 1995;92(1):131–135.
   PubMed Web of Science ®Google Scholar
• Macleod RJ. CaSR function in the intestine: hormone secretion, electrolyte absorption and secretion, paracrine non-canonical Wnt signaling and colonic crypt cell proliferation. Best Pract Res Clin Endocrinol Metab. 2013;27(3):385–402.
   PubMed Web of Science ®Google Scholar
• Aggarwal KP, Narula S, Kakkar M, et al. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int. 2013;2013:292953.
   PubMed Web of Science ®Google Scholar
• Koul HK, Menon M, Chaturvedi LS, et al. COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem. 2002;277(39):36845–36852.
   PubMed Web of Science ®Google Scholar
• Smajilovic S, Tfelt-Hansen J. Novel role of the calcium-sensing receptor in blood pressure modulation. Hypertension. 2008;52(6):994–1000.
   PubMed Web of Science ®Google Scholar
• Cao LC, Jonassen J, Honeyman TW, et al. Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. Am J Nephrol. 2001;21(1):69–77.
   PubMed Web of Science ®Google Scholar
• Bigelow MW, Wiessner JH, Kleinman JG, et al. Surface exposure of phosphatidylserine increases calcium oxalate crystal attachment to IMCD cells. Am J Physiol. 1997;272(1 Pt 2):F55–F62.
   PubMedGoogle Scholar
• Miano R, Germani S, Vespasiani G. Stones and urinary tract infections. Urol Int. 2007;79(Suppl. 1):32–36.
   PubMedGoogle Scholar
• McLean RJ, Nickel JC, Noakes VC, et al. An in vitro ultrastructural study of infectious kidney stone genesis. Infect Immun. 1985;49(3):805–811.
   PubMed Web of Science ®Google Scholar
• Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, et al. Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012;27(11):4125–4130.
   PubMed Web of Science ®Google Scholar
• Chutipongtanate S, Sutthimethakorn S, Chiangjong W, et al. Bacteria can promote calcium oxalate crystal growth and aggregation. J Biol Inorg Chem. 2013;18(3):299–308.
   PubMed Web of Science ®Google Scholar
• Barr-Beare E, Saxena V, Hilt EE, et al. The interaction between Enterobacteriaceae and calcium oxalate deposits. PLoS One. 2015;10(10):e0139575.
   PubMed Web of Science ®Google Scholar
• Morimoto J, Kon S, Matsui Y, et al. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets. 2010;11(4):494–505.
   PubMed Web of Science ®Google Scholar
• Tsigou E, Psallida V, Demponeras C, et al. Role of new biomarkers: functional and structural damage. Crit Care Res Pract. 2013;2013:361078.
   PubMedGoogle Scholar
• Han WK, Wagener G, Zhu Y, et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009;4(5):873–882.
   PubMed Web of Science ®Google Scholar
• Wang W, Gou X, Xue H, et al. Ganoderan (GDN) regulates the growth, motility and apoptosis of non-small cell lung cancer cells through ERK signaling pathway in vitro and in vivo. Onco Targets Ther. 2019;12:8821–8832.
   PubMed Web of Science ®Google Scholar
• Matsubayashi Y, Ebisuya M, Honjoh S, et al. ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing. Curr Biol. 2004;14(8):731–735.
   PubMed Web of Science ®Google Scholar
• Schepers MS, van Ballegooijen ES, Bangma CH, et al. Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations. Kidney Int. 2005;68(4):1660–1669.
   PubMed Web of Science ®Google Scholar
• Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res. 2006;34(2):86–91.
   PubMedGoogle Scholar
• Mitchell T, Kumar P, Reddy T, et al. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019;316(3):F409–F413.
   PubMed Web of Science ®Google Scholar
• Hess B, Jordi S, Zipperle L, et al. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former. Nephrol Dial Transplant. 2000;15(3):366–374.
   PubMed Web of Science ®Google Scholar